Logo image of TIRX

TIAN RUIXIANG HOLDINGS LTD-A (TIRX) Stock Analyst Earnings Estimates

NASDAQ:TIRX - Nasdaq - KYG8884K1287 - Common Stock - Currency: USD

1.78  -0.02 (-1.11%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
TIRX revenue by date.TIRX revenue by date.
2.791M
-14.12%
1.352M
-51.56%
1.244M
-7.96%
EBITDA
YoY % growth
TIRX ebitda by date.TIRX ebitda by date.
-2.226M
-478.69%
-4.922M
-121.10%
-3.015M
38.75%
EBIT
YoY % growth
TIRX ebit by date.TIRX ebit by date.
-2.254M
-502.39%
-4.945M
-119.42%
-3.016M
39.01%
Operating Margin
TIRX operating margin by date.TIRX operating margin by date.
-80.76%-365.80%-242.42%
EPS
YoY % growth
TIRX eps by date.TIRX eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
TIRX Yearly EPS VS EstimatesTIRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
178.35K
-75.40%
%
Q4 2023
Q2Q % growth
519.39K
27.83%
%
Q2 2023
Q2Q % growth
724.86K
-23.35%
%
Q4 2022
Q2Q % growth
406.3K
-85.44%
%
Q3 2022
Q2Q % growth
406.26K
-85.44%
%
Q2 2022
Q2Q % growth
945.7K
-42.22%
%
Q1 2022
Q2Q % growth
945.65K
-42.23%
%
TIRX Yearly Revenue VS EstimatesTIRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A